Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 54: 1657-1663, 2008. First published August 14, 2008; 10.1373/clinchem.2008.107870
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2008.107870v1
54/10/1657    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Battistella, S.
Right arrow Articles by Cremonesi, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Battistella, S.
Right arrow Articles by Cremonesi, L.
(Clinical Chemistry. 2008;54:1657-1663.)
© 2008 American Association for Clinical Chemistry, Inc.


Molecular Diagnostics and Genetics

Genotyping β-Globin Gene Mutations on Copolymer-Coated Glass Slides with the Ligation Detection Reaction

Stefania Battistella1, Francesco Damin2, Marcella Chiari2, Kathleen Delgrosso3, Saul Surrey3, Paolo Fortina4,5, Maurizio Ferrari1,6,7 and Laura Cremonesi1,a

1 Genomic Unit for the Diagnosis of Human Pathologies, San Raffaele Scientific Institute, Milano, Italy; 2 Istituto di Chimica del Riconoscimento Molecolare (ICRM), C.N.R., Milano, Italy; 3 Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA; 4 Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA; 5 Dipartimento di Medicina Sperimentale e Patologia, Universita’ degli Studi "La Sapienza," Roma, Italy; 6 Ricerca e Diagnostica San Raffaele, Milano, Italy; 7 Universita’ Vita-Salute San Raffaele, Milano, Italy.

aAddress correspondence to this author at: Genomic Unit for the Diagnosis of Human Pathologies, DIBIT2, San Raffaele Scientific Institute, Via Olgettina 60 Milan, 20132 Milan, Italy. Fax 0039 02 26434351; e-mail cremonesi.laura{at}hsr.it.

Background: Methods are needed to analyze small amounts of samples for variation in disease-causing genes. One means is to couple the sensitivity and multiplexing capability of the ligation detection reaction (LDR) with the use of simple glass slides specifically functionalized with a novel polymer coating to enhance sensitivity.

Methods: We developed an array-based genotyping assay based on glass slides coated with copolymer (N,N-dimethylacrylamide, N,N-acryloyloxysuccinimide, and 3-(trimethoxysilyl)propyl methacrylate). The assay consists of an LDR with genomic DNA followed by a universal PCR (U-PCR) of genomic DNA–templated LDR product. The LDR occurs in the presence of 3 primers for each sequence variant under investigation: 2 distinguishing primers (allele specific and perfectly complementary to wild-type and mutant alleles) and 1 common locus-specific primer. The 2 allele-specific primers have different capture sequences for binding different complementary probes on a tag array. The LDR product templated from genomic DNA is made fluorescent during the U-PCR via incorporation of a Cy5-labeled universal primer into all LDR products; detection occurs on the coated glass slides.

Results: The assay was designed to detect 7 prevalent mutations in the β-globin gene (HBB, hemoglobin, beta) in a multiplex format, and signals for the different alleles are detected by their fluorescence. The assay was applied to 40 genomic DNA samples from both control individuals and patients with known β-thalassemia mutations. Results show good correspondence between the patients’ genotypes as assessed by DNA sequence analysis and those generated from the LDR assays.

Conclusions: The developed technology allows accurate identification of sequence variants in a simple, cost-effective way and offers good flexibility for scaling to other applications with different numbers of single-nucleotide polymorphisms or mutations to be detected.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.